OTCM
NUNZ
Market cap43kUSD
Jun 05, Last price
0.00USD
Name
Nunzia Pharmaceutical Corp
Chart & performance
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0
Net income
0
P
CFO
0
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders. It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.
Key people
R. Steve Mills
Chairman of the Board, Chief Executive Officer · since 2005
Kingman Hitz
Chief Financial Officer, Vice President · since 2005
Roger Kron
Chief Operating Officer, Senior Vice President, Treasurer, Secretary, Director · since 2005
G.David Henry
Director · since 2004
Mary Pohlmeier
Director · since 1991
Robin Sandifer
Director · since 1997
Headquarters & legal address
C/O Parson & West, P.C.
299 South Main Street
Suite 1300
Salt Lake City, UT 84111
US
299 South Main Street
Suite 1300
Salt Lake City, UT 84111
US
Previous name
Silver Harvest, Inc.
Previous name
Viking Capital Group, Inc.
Previous name
The Institute For Financial Fitness, Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT | ||||||